Back
Virtus LifeSci Biotech Clinical Trls ETF Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
BBC
Virtus LifeSci Biotech Clinical Trls ETF
Last Price:
26.53
Seasonality Move:
8.49%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Virtus LifeSci Biotech Clinical Trls ETF Price Quote
$26.53
-0.32 (0%)
(Updated: November 23, 2024 at 5:26 AM ET)
Virtus LifeSci Biotech Clinical Trls ETF Key Stats
Sell
35
Virtus LifeSci Biotech Clinical Trls ETF (BBC)
is a Sell
Day range:
$26.84 - $26.91
52-week range:
$18.77 - $31.99
Dividend yield:
0.31%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
2.3K
Avg. volume:
1.9K
1-year change:
42.01%
Market cap:
$0
Revenue:
$0
EPS:
$0
How Much Does Virtus LifeSci Biotech Clinical Trls ETF Make?
Data Unavailable
Is Virtus LifeSci Biotech Clinical Trls ETF Growing As A Company?
Data Unavailable
Virtus LifeSci Biotech Clinical Trls ETF Stock Price Performance
-
Did Virtus LifeSci Biotech Clinical Trls ETF Stock Go Up Last Month?
Virtus LifeSci Biotech Clinical Trls ETF share price went down by -10.2% last month -
Did BBC's Share Price Rise Over The Last Year?
BBC share price rose by 42.01% over the past 1 year
What Is Virtus LifeSci Biotech Clinical Trls ETF 52-Week High & Low?
-
What Is Virtus LifeSci Biotech Clinical Trls ETF’s 52-Week High Share Price?
Virtus LifeSci Biotech Clinical Trls ETF has traded as high as $31.99 over the past 52 weeks -
What Is Virtus LifeSci Biotech Clinical Trls ETF’s 52-Week Low Share Price?
Virtus LifeSci Biotech Clinical Trls ETF has traded as low as $18.77 over the past 52 weeks
Virtus LifeSci Biotech Clinical Trls ETF Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Virtus LifeSci Biotech Clinical Trls ETF?
Data Unavailable
Is Virtus LifeSci Biotech Clinical Trls ETF Cash Flow Positive?
Data Unavailable
Virtus LifeSci Biotech Clinical Trls ETF Return On Invested Capital
Data Unavailable
Virtus LifeSci Biotech Clinical Trls ETF Earnings Date & Stock Price
-
What Is Virtus LifeSci Biotech Clinical Trls ETF's Stock Price Today?
A single share of BBC can be purchased today for 26.85 -
What Is Virtus LifeSci Biotech Clinical Trls ETF’s Stock Symbol?
Virtus LifeSci Biotech Clinical Trls ETF trades on the nysearca under the ticker symbol: BBC -
When Is Virtus LifeSci Biotech Clinical Trls ETF’s Next Earnings Date?
The next quarterly earnings date for Virtus LifeSci Biotech Clinical Trls ETF is scheduled on November 25, 2024 -
When Is BBC's next ex-dividend date?
Virtus LifeSci Biotech Clinical Trls ETF's next ex-dividend date is December 20, 2023 -
How To Buy Virtus LifeSci Biotech Clinical Trls ETF Stock?
You can buy Virtus LifeSci Biotech Clinical Trls ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Virtus LifeSci Biotech Clinical Trls ETF Competitors
-
Who Are Virtus LifeSci Biotech Clinical Trls ETF's Competitors?
Below is a list of companies who compete with Virtus LifeSci Biotech Clinical Trls ETF or are related in some way:
Virtus LifeSci Biotech Clinical Trls ETF Dividend Yield
-
What Is BBC Dividend Yield?
Virtus LifeSci Biotech Clinical Trls ETF’s dividend yield currently is 0.31% -
What Is Virtus LifeSci Biotech Clinical Trls ETF’s Payout Ratio?
Virtus LifeSci Biotech Clinical Trls ETF’s payout ratio is 0% -
When Did Virtus LifeSci Biotech Clinical Trls ETF Last Pay A Dividend?
The latest dividend pay date is November 25, 2024 -
What Is Virtus LifeSci Biotech Clinical Trls ETF’s Dividend Per Share?
Virtus LifeSci Biotech Clinical Trls ETF pays a dividend of $0.00 per share
Virtus LifeSci Biotech Clinical Trls ETF Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable